Matthieu Gregoire

21PUBLICATIONS
33CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsGene and molecular therapyMedical biochemistry - proteins and peptides (incl. medical proteomics)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 29, 2026
Protein Binding Determination of Cefepime, Flucloxacillin, Meropenem, Piperacillin and Tazobactam by Ultrafiltration in Critically Ill Patients: The Choice of Device Matters.

|Jun 27, 2026
Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy.

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

|Oct 17, 2025
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections.

Eva Benavent, Jaime Lora-Tamayo, Marta Ulldemolins

|Aug 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Nadège Néant, Minh P Lê, Stéphane Bouchet

|Aug 13, 2025
A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics model.

Emmanuel Enard, Matthieu Grégoire, Éric Dailly

Pageof 4

Frequent Collaborators

5 joint publications

Ronan Bellouard

4 joint publications

Florian Lemaitre

3 joint publications

Jean-François Huon

3 joint publications

Minh P Lê